Several genome-wide association studies have been conducted to investigate the influence of genetic polymorphisms in the development of allergic diseases, but few of them have included the X chromosome. The aim of present study was to perform an X chromosome-wide association study (X-WAS) for asthma symptoms. The study included 1307 children of which 294 were asthma cases. DNA was genotyped using 2.5 HumanOmni Beadchip from Illumina. Statistical analyses were performed in PLINK 1.9, MACH 1.0 and Minimac2. The variant rs12007907 (g.29483892C4A) in IL1RAPL gene was suggestively associated with asthma symptoms in discovery set (odds ratio (OR) = 0.49, 95% confidence interval (CI): 0.37-0.67; P = 3.33 × 10 −6 ). This result was replicated in the ProAr cohort in men only (OR = 0.45, 95% CI: 0.21-0.95; P = 0.038). Furthermore, investigating the functional role of the rs12007907 on the production a Th2-type cytokine, IL-13, we found a negative association between the minor allele A with IL-13 production in the discovery set (P = 0.044). Gene-based analysis revealed that NUDT10 was the most consistently associated with asthma symptoms in discovery sample. In conclusion, the rs12007907 variant in IL1RAPL gene was negatively associated with asthma and IL-13 production in our study and a sex-specific association was observed in one of the validation samples. It suggests an effect on asthma susceptibility and may explain differences in severe asthma frequency between women and men.
INTRODUCTION
Asthma affects the low airways resulting in airflow obstruction, bronchial hyper-responsiveness and inflammation. 1 The most recent Global Asthma Report estimates that over 334 million people are affected by asthma worldwide. 2 This prevalence is increasing in recent decades among individuals living in industrialized countries and, more recently, in developing countries. Therefore, asthma is considered a public health problem. [3] [4] [5] [6] Asthma is a complex disease and the mechanisms responsible for its causation are not fully understood, although it is clear that genetic and environment factors play an important role in its pathogenesis. 7, 8 Many genome-wide association studies (GWAS) have been conducted to investigate the influence of genetic polymorphisms in the development of several diseases. It is estimated that almost 1400 GWAS have identified~2800 peak associations (Pr5.10 − 8 ) so far. 9 However, o30% of these studies report the X chromosome in their analysis. This may happened for several reasons, including the limited number of X chromosome single-nucleotide polymorphisms (SNPs) presented in some genotyping platforms and the difference in the number of X chromosome copies between men and women, which complicate the association analysis.
The X chromosome contains 2300 genes 10 and almost 1,3M SNPs. 4 Genes present in the X chromosome are associated with different genetic diseases such as Duchenne muscular dystrophy, 11 Hemophylia A 12 and IPEX (immune dysfunction, polyendocrinopathy, enteropathy and X-linked) syndrome. 13 In addition, this chromosome includes genes that have been associated with allergic diseases, such as FOXP3 14 and others, which may be of relevance in the context of asthma, such as the TLR7 and TLR8. 15 Thus, analyzing SNPs present in this chromosome may provide important insights regarding genetic variants associated with diseases and should not be neglected. This is of special interest in the asthma context, where differences in prevalence, morbidity and severity of the disease according to gender have been reported. 16, 17 These studies have shown that males are more affected during early childhood but a gender shift has been observed at puberty, with a higher prevalence of asthma in females at adulthood. Factors contributing to such sex difference remain unclear and may involve hormonal changes together with genetic predisposition.
Considering the presence of important genes on the X chromosome, possible associations with complex diseases and difficulties in analyzing X-linked markers in GWAS, several studies have analyzed the X chromosome separately. [18] [19] [20] Therefore, the aim of this study was to perform an X chromosome-wide association study (X-WAS) for asthma symptoms in childhood. To our knowledge, this is the first X-WAS for asthma conducted worldwide.
METHODS

Study design and population characterization
As described in previous publications, [21] [22] [23] Social Changes, Asthma and Allergy in Latin America (SCAALA) is a research program conducted in Brazil and Ecuador. The Brazilian component comprised a cohort of 1307 (705 males) unrelated children between 4 and 11 years old. Asthma symptoms were defined and classified as reported in a previous publication of SCAALA Salvador studies. 24 Briefly, children were classified as having current wheeze as previously described 25, 26 by using phase II International Study of Asthma and Allergies in Childhood questionnaire (wheezing in the last 12 months) and were considered to have current wheeze plus symptoms if parents reported wheezing in the previous 12 months and at least one of the following: (1) diagnosis of asthma ever; (2) wheezing with exercise in the last 12 months; (3) four or more episodes of wheezing in the last 12 months; and (4) waking up at night because of wheezing in the last 12 months. Ethical approval for this study was obtained from the Brazilian National Ethical Council, and written informed consent was obtained from the guardian of each child.
Genotyping and quality control DNA was extracted from peripheral blood using a commercial kit (Gentra Puregene Blood Kit (Qiagen, Germantown, ML, USA)). Subjects were genotyped using the 2.5HumanOmni Beadchip from Illumina (San Diego, CA, USA). There were 46 945 SNPs genotyped on X chromosome and 391 SNPs in pseudoautossomal regions between the X and Y chromosomes. Genotyping quality control and data cleaning was performed as specified in Kehdy et al. 27 Closely related individuals (n = 64) identified as in Kehdy et al. 27 were excluded. SNPs were removed if MAF (minor allele frequency) r 1% in males and females separately. SNPs were also excluded if MIF (missing frequency) was ≥ 2% threshold either the separated missing frequencies in males and females (MIF males-MIF females). Genotyping data has been deposited at the European Genome-phenome Archive (EGA, http://www.ebi.ac. uk.ega/), which is hosted by the EBI, under accession number EGAS00001001245.
Sequence annotations
Comparative genomic data and regulatory features for the IL1RAPL1 gene (X: 29418224-29545784; GRCh37/hg19 reference sequence) were obtained from both the Ensembl (http://www.ensembl.org) and University of California Santa Cruz (http://genome.ucsc.edu) genome browsers. SNP positions were cross-referenced with sequence annotations, including genomic evolutionary rate profiling-constrained elements for 36 eutherian mammals (GERP-EPO low coverage), 28 chromatin segmentation state, and enrichment for marks of open chromatin (DNase I hypersensitive sites). These last two types of information were obtained from the ENCODE project. 29 
Validation studies
Validation analyses were performed in independent Brazil and US Latin American populations. The US Latin American samples dates were collected from Genes-environments and Admixture in Latino Americans study (GALA II). The GALA II study is an ongoing multicenter case-control study of asthma in Latino children and adolescents (1893 asthma cases and 1881 controls), organized from the coordinating center based at the University of California, San Francisco, CA, USA. 30 Subjects were eligible if they were 8-21 years old and had no history of other lung or other chronic illnesses. Asthma was defined based on physician diagnosis and report of symptoms and medication use within the past 2 years before the recruitment. Controls had no reported history of asthma, lung disease or chronic illness, allergic disease (eczema, hives, hay fever and allergic rhinitis), no reported use of medication for allergies, and no reported symptoms of coughing, wheezing or shortness of breath in their lifetime.
The second replication set was the Pelotas birth cohort from Brazil. 31 It is comprised of 1151 participants (343 asthma cases and 808 health individuals), which were interviewed when they were 18 years of age. Asthma was defined based on the same criteria used to case definition in the SCAALA cohort.
The third replication set was the Asthma and Allergic Rhinitis Control Program in Bahia (ProAR). Cases were comprised of 420 patients with severe asthma and 305 patients with mild or intermittent control persistent asthma according to the Global Initiative rating against Asthma 32 from both genders and age ≥ 18 years, living in Salvador. Controls were comprised with 398 subjects without history of asthma, residing in Salvador and unrelated of the cases. In this replication study, the rs12007907 genotyping was performed using TaqMan probe-based 5′-nuclease assays (Applied Biosystems, Foster City, CA, USA) in QuantStudio 12k Flex equipment.
Cytokine production
Venous blood was collected into heparinised tubes and the collected cells were cultured as previously described by Figueiredo et al. 33 The production IL-5 and IL-13 upon pokeweed (PWM) stimulation was measured in whole-blood culture supernatants using commercially available antibody pairs and recombinant cytokine standards (BD Biosciences Pharmingen, San Diego, CA, USA) by sandwich ELISA according to the manufacturer's instructions. Cytokine concentrations were determined by interpolation of standard curves. 33 
Statistical analysis
Logistic regression analyses using additive genetic model for asthma were performed in PLINK 1.9 after filters application for quality control procedures. Analyses were adjusted by sex, age and the first three principal components (PCs) delineated through Eigenstrat on 370 539 genome-wide autosomal SNPs as covariates. Because of sex-biased pattern of admixture in Brazilian populations, with preferential mating between males with predominant European ancestry and women with predominant African or Amerindian ancestry, 34 the non-European ancestry inferred to the X chromosome tend to be higher than estimated for the autosomes. 27 For this reason, the average local ancestry inferred for X chromosome has been used as covariate in some analyzes. Details about the methodology used to infer X chromosome ancestry are described elsewhere. 27 Based on the default of PLINK, the analysis were performed assuming no dosage compensation. Thus male genotypes were coded as 0 or 1 and female genotypes were coded as 0, 1 or 2. Sex-stratified analyses were performed for taking into account the X-inactivation and different effect sizes of X-linked SNPs between males and females. For this, data from each sex (cases and controls) were analyzed separately and then combined using a weighted Stouffer's method. 35 To test for differences in effect size according to sex we performed tests of heterogeneity using the METAL program. 35 The SNP imputation pre-phase for the first step was performed in MACH 1.0 and the second phase in Minimac2 36,37 and was run separately for males and females. For imputation we used as reference the African population (1000G.AFR, 20100804.tgz) according 1000 genomes. 4 We imputed with high confidence (R 2 = 0.3). To obtain a normal distribution of cytokines values a log transformation was applied and the differences in cytokines concentration among the rs12007907 genotypes were analyzed using linear regression adjusted for sex, age and the three PCs of genetic ancestry using 370 539 genome-wide autosomal SNPs.
Gene-based association analysis
Gene-based association tests were performed through VEGAS2 38 and MAGMA 39 software. Briefly, this approach aggregate association signals considering all SNPs within a gene while account for dependence between signals due to linkage disequilibrium (LD) to assign a level of significance for the association of the gene overall. In addition, MAGMA also performs gene-based analysis using PC regression and this method was applied for comparison with the results based on P-value that were obtained in VEGAS2 and MAGMA. In all gene-based analyzes empirical P-values were obtained through permutational methods, being performed 10.000 simulations in VEGAS2 and 100.000 in MAGMA.
RESULTS
The final data set, after quality control for SNPs and individuals, included 35 410 SNPs and 1246 samples (280 cases). We have identified two markers in X chromosome suggestively associated with asthma symptoms (Figure 1) . Table 1 presents the top 20 SNPs ranked according to P-value. The strongest association was observed for the SNP rs12007907 (odds ratio (OR) = 0.49, 95% confidence interval (CI): 0.37-0.67; P = 3.33 × 10 − 6 ), which is an intronic variant located in the IL1RAPL1 (IL-1 R acessory protein-like) gene. The second most significantly associated variant was the rs199522937 (OR = 1.71, 95% CI: 1.35-2.14; P = 5.11 × 10 − 6 ) located in an intergenic region 5 kb upstream of the DACH2 gene (Dachshund Family Transcription Factor). These results were virtually unchanged when using the ancestry inferred to the X chromosome to adjust by population stratification (OR = 0.49, 95% CI: 0.36-0.66; P = 3.10 × 10 − 6 for rs12007907 and OR = 1.71, 95% CI: 1.36-2.15; P = 4.57 × 10 − 6 ; for rs199522937). Likewise, the rs12007907 and rs199522937 SNPs remained as being most associated with asthma symptoms when the results obtained for males and females separately were combined by the weighted Stouffer's method (Supplementary Table 1 ). This supports validity of the findings when one takes into account the possibility of differential effect size and direction between males and females as well X-inactivation (that is, males coding as 0 and 2 instead 0 and 1 as assumed in the analysis).
The quantile-quantile-plot (QQ-plot) of the P-values illustrates that the observed significant associations were beyond those expected by chance (Figure 2) . Furthermore, estimated genomic inflation factor (λ) was = 1, indicating that population genetic structure had negligible impact on association results. Regional plot of logistic regression in genotyped and imputed data were performed for the most associated region with asthma symptoms in X chromosome (Figure 3 ). Since the rs12007907 and other SNPs of IL1RAPL1 gene are very rare in nonAfrican populations, we performed the imputation using the African population (1000G.AFR, 20100804.tgz) according 1000 genomes as the reference population. The SNP rs12007907 is in high LD with other SNPs in the IL1RAPL1, suggesting that variants of this gene are most likely associated with asthma symptoms in this genomic region. We carried out an in silico analysis of the SNPs correlated (r 2 ≥ 0.6) with rs12007907 to identify putative functional variants in the IL1RAPL1 region. We evaluated various functional annotations in our sets of polymorphisms, including predicted chromatin state segmentation, predicted DNAse hypersensitivity, and sequence conservation across mammals (Supplementary Table 2 ). This analysis revealed that rs714723 was the best candidate for a functional variant in the rs12007907 LD block. This SNP is located within a CCCTCbinding transcription factor (CTCF) sequence and can alter CTCF Figure 1 Manhattan plot of X chromosome-wide association results. The line corresponds to threshold for suggestive associations (Po5.0 × 10 − 6 ) adopted in logistic regression analyses performed using additive genetic model for asthma and adjusted by sex, age and the first three principal components of ancestry markers. affinity to this genomic region. Analysis using imputed data confirmed the suggestive association of rs714723 and other variants in the rs12007907 LD block with symptoms of asthma in our population (Figure 3 and Supplementary Table 2) . We followed-up the association of rs12007907 with asthma in three independent validation cohorts for which information about this SNP were available. (Supplementary Table 3) . In GALA II and Pelotas populations the rs12007907 was not associated with asthma (OR = 1.06, 95% CI: 0.92-1.23; P = 0.420 and OR = 1.26, 95% CI: 0.91-1.73; P = 0.164, respectively). In the ProAr cohort, which was recruited in the same city and is ethnically similar to the discovery sample of this study, although no significant association was observed between rs12007907 and asthma in general analysis (OR = 0.96, 95% CI: 0.78-1.18; P = 0.707), the rs12007907 was negatively associated with asthma among men (OR = 0.45, 95% CI: 0.21-0.95; P = 0.038) but not among women (OR = 1.02, 95% CI: 0.82-1.26; P = 0.862). Otherwise, in the GALA II and Pelotas populations the results remained not significant when stratifying by sex. Also in the discovery set no differences according to sex were observed for the association between rs12007907 and asthma (OR = 0.59, 95% CI: 0.38-0.95; P = 2, 9 × 10 − 2 and OR = 0.43, 95% CI: 0.29-0.64; P = 2.4 × 10 − 5 among men and women, respectively).
Since Th2-type cytokine are associated with atopic asthma 40 and considering that IL1 family members such as (IL33/ST2) components induce Th2 polarization, 41 we analyzed the production of IL-5 and IL-13 in PWM-stimulated whole-blood cultures according to the genotypes for our top SNP (rs12007907). As can be seen in Figure 4 , the homozygote for A allele had a lower production of IL-13 in comparison with homozygote for C allele. The geometric mean of IL-13 concentration in AA genotype was 36% lower compared with the CC genotype (P = 0.044). No statistically significant differences were observed comparing the heterozygous (CA) to the CC genotype (P = 0.278). The Kruskal-Wallis test also showed significant differences for IL-13 production between the different genotypic groups of rs1200797 (P = 0.044). No significant trend was found for IL-5 production according to rs12007907 genotype (data not shown).
The results of heterogeneity tests are shown in Supplementary  Table 4 . The rs56025647 was the top SNP for sex-differentiated effect size in risk for asthma on SCAALA cohort, although it did not reach a level of suggestive association considering multiple heterogeneity tests (P = 5.15 × 10 − 5 ). Among males, this SNP was positively associated with asthma symptoms (OR: 1.84, 95% CI: 1.25-2.71, P = 1,88 × 10 − 3 ), while among females it was negatively associated (OR: 0.56, 95% CI: 0.40-0.78, P = 8, 5 × 10 − 4 ). The regional plot of SNPs near to rs56025647 is showed in Supplementary Figure 1 .
The results of gene-based analysis are showed in the Supplementary  Figure 2 and Supplementary Table 5 . The NUDT10 was the only significantly associated gene with asthma symptoms (empirical P-valueo0.01) in both analyses based on previously computed SNP P-values (MAGMA and VEGAS) as well as on PCs regression (MAGMA).
The 100 SNPs most associated with asthma symptoms in the discovery set and ranked according to the P-value are shown in Supplementary Table 6 .
DISCUSSION
The X chromosome has been often overlooked in GWAS of asthma to date. An important exception in this scenario is the Moffat et al study, 42 which performed X chromosome analysis in populations with predominant European ancestry but reported no statistically significant association signals. Recently, a GWAS of asthma symptoms in Latin American children with remarkable African ancestry was carried out in the same cohort of present study, but the X chromosome was excluded from the analyses. 43 However, X-WAS studies can help clarify the role of several genes in the development of many diseases, including complex illnesses such as asthma. In this context, this is to the best of our knowledge one of the first initiatives to perform an X-WAS for asthma symptoms in Latin American children to date.
In our discovery sample two SNPs were suggestively associated with asthma symptoms. The SNP rs199522937 are intergenic and located in an upstream region of DACH2 gene that encodes a 599 aminoacid protein that is a transcriptional cofactor. 42 DACH2 sequences suggest a role in abnormalities like cleft palate and megalocornea. 43 While the association of this intergenic SNP with asthma seems unclear, the top SNP in our study, located in the IL1RAPL1 gene region, suggest a possible causal effect on asthma susceptibility. The IL1RAPL1 (IL-1R accessory protein-like) is a gene that encodes a protein with 696 aminoacids homologous to IL-1 receptor accessory proteins. IL1RAPL was first identified in patients with X-linked mental retardation. 44 Mutations in this gene were also identified in patients with cognitive impairment. In these cases, a loss-of-function mutation in this gene impacts on an interleukin/MAP kinase cascade of modulatory neurotransmitters affecting synapse structure leading to cognitive impairment. 44 The exact function of IL1RAPL1 is not fully understood, but it is abundantly expressed in postnatal brain structures and may interact with neuronal calcium sensor, thus possibly acting in regulation of exocytosis of secretory substances. The expression of IL1RAPL protein has been detected in the brain, heart and muscle. 45 Khan et al showed that IL1RAPL can active c-Jun amino-terminal kinases (JNKs) but not extracellular signal-regulated kinases (ERKs) nor mitogen-activated protein kinases (MAPKs). 46 Although IL1R have high affinities for their ligands, the accessory proteins cannot do it directly. Furthermore, the function of IL1RAPL might be more related to the Toll-like receptors subfamily than IL1R subfamily. 45 Interestingly, IL1RAPL1 has already been reported in two previous GWAS to be associated with cardiovascular disease 47 and autism. 19 Although this gene belongs to the IL1R family, it has been poorly studied, possible due to its localization in the X chromosome and consequent exclusion from genome-wide analysis. The rs12007907 is an intronic SNP which is in LD with others SNPs located in a regulatory region of the IL1RAPL1 gene, such as the rs714723 variant located within a CTCF sequence. Binding of target sequence elements by CTCF can block the interaction between enhancers and promoters, therefore limiting the activity of enhancers to certain functional domains. CTCF can also act as a chromatin barrier by preventing the spread of heterochromatin structures. 48 The primary role of CTCF is thought to be in regulating the structure of chromatin. Therefore, SNPs located in these regions could influence gene expression. However, further analyzes including functional assays are required to identify potential causal polymorphisms located in IL1RAPL gene or even in nearby genomic regions.
Different IL-1 receptors, such as IL-1R, are found in the human genome and the IL1RAPL is a member of this subfamily. IL-1R is potential regulator of inflammation and is critical for innate immunity and host defense against infections. 31 IL-1R also play an important role in the regulation of TH2 cell in allergic airway inflammation. 41 Previous GWASs reported associations of IL1R SNPs with asthma in different populations, [49] [50] [51] suggesting that IL1R gene may be involved in asthma susceptibility. Assuming that IL1RAPL gene may play a similar role of IL1R in inflammatory responses mediated by TH2 cells, we decided to evaluate the association between the rs12007907 genotypes and the production of Th2-type cytokines (IL-5 and IL-13) in our study population. Interestingly, the homozygous genotype for the rs1200797 allele negatively associated with asthma symptoms (AA genotype) was negatively associated with IL-13 production. These results suggest a possible involvement of SNPs in IL1RAPL1 gene regulating IL-13 production, which needs to be further, investigated. However, that could also explain the negative association observed for rs12007907 with asthma since IL-13 is a classical cytokine related to allergic asthma leading to bronchial hyper reactivity as well as mucus production. 52 In our validation samples we did not observe significant associations in general analysis. This can be explained, at least in part, by differential frequencies of IL1RAPL1 SNPs between the populations evaluated. In fact, a pattern of biogeographical variation is observed for rs12007907, with allele frequencies varying from 37% among Africans, 3% among Europeans and 7% among Amercan Indians. In SCAALA (the discovery sample) rs12007907 MAF (corresponding to the A allele) was 25%, reflecting the remarkable African contribution to this admixed population. 45 In the ProAr cohort the frequency of this SNP was 23%, which reflects the closest genetic similarity of this population with the discovery sample. However, in the GALA II and Pelotas cohorts the MAFs were 7 and 11%, respectively, which may result in a lack of statistical power to detect an association. In addition, in the Pelotas cohort the outcome of asthma symptoms was investigated during adolescence. 31 Also, GALA II consists of adolescents and young adults, 30 while the ProAr cohort is exclusively composed of adult individuals and asthma phenotype different from SCAALA (SCAALA cohort which comprises mild asthmatics only while ProAr mild and severe asthmatics). Given the heterogeneity of asthma across different stages of the life course, it is possible that genetic variants associated with childhood-onset disease are not the same implicated in late-onset disease, which is in accordance to evidence from GWAS. 42 Interestingly, in the analysis stratified by sex the rs12007907 was negatively associated with asthma among men in ProAR cohort, in agreement with that observed in the discovery set. These results suggest that studies in admixed populations with predominantly non-European ancestry can shed light on genetic factors involved in gender differences for asthma prevalence.
Gene-based analysis revealed that NUDT10 was the most consistently associated with asthma symptoms in SCAALA-Salvador cohort. This gene belongs to NUDT gene family (NUDT = 'Nudix [Nucleoside Diphosphate attached moiety 'x']-Type motif) and encode a phosphatase involved in the diphosphoinositol polyphosphates cell turnover. 46 The diphosphoinositol polyphosphates have been implicated in several cellular activities, such as homolog recombination, vesicle trafficking, apoptosis and response to environmental stress. [47] [48] [49] Although association of the NUDT genes with asthma has not been previously reported, the diphosphoinositol polyphosphates syntheses is activated in cells subjected to stress by hyperosmotic pressure. 50 Such osmotic stress may occur, for instance, in airways epithelial cells undergone to inadequate airway humidification caused by rapid breathing (for example, during exercise), breathing of dry/cold air and in some airway diseases. 51 Interestingly, the hyperosmolality of extracellular fluid is believed to play an inflammatory role in asthma and other diseases. 52 However, further studies are needed to clarify the role, if any, of NUDT10 gene in asthma risk.
For complex diseases exhibiting sexual dimorphism, such as asthma, it is supposed that X-linked variants are more likely to exhibit different effects between males and females. 53 Therefore, we performed stratified analyzes in order to identify potential variants with different effect size in asthma symptoms according to sex. The top SNP in the heterogeneity tests, rs56025647, is located in an intergenic region in Xq13. The role of genetic variants in this locus to asthma risk, however, is unknown and needs to be further investigated.
An important limitation of the present study is the relatively small sample size, which can lead to lack of power, especially because SNPs generally have small effect size. Considering an OR of 1.5 and a significance level of 5.0 × 10 − 8 , for example, the power reached by the study is only 30.5 and 41.2% for variants with frequencies of 20 and 25%, respectively. Although not calculated, the power reached by the study in analyzes stratified by sex is even lower. Nevertheless, suggestive associations were detected when correcting for multiple testing in overall sample. However, these results require further replication in more similar samples regarding their genetic background and age, which shall be complemented with functional data to understand the impact of these herein described genes in asthma.
CONCLUSION
This is the first X chromosome-wide association study for asthma carried out to date. Our findings showed that X-linked genes were suggestively associated with asthma symptoms in children, one of which belongs to IL1R's family. This latter gene was also associated with production of pro-inflammatory cytokine IL-13. Though the X chromosome is often excluded from GWAS, important differences in morbidity and severity of asthma has been reported between males and females. This prevents the assessment of the impact of sex-linked genes in asthma. Thus our study may contribute to a better understanding of genetic factors involved in asthma development and, in particular, to the observed gender differences.
